Valeant forms interim office as CEO goes on medical leave of absence

Valeant Pharmaceutical International announced in a press release that J. Michael Pearson, its chairman and CEO, is on medical leave of absence. An Office of the Chief Executive Officer has been created by Valeant’s board of directors and will include Robert Chai-Onn, executive vice president and general counsel, Ari Kellen, MBBCh, MBA, executive vice president and company chairman, and Robert Rosiello, executive vice president and chief financial officer, who will serve in an interim capacity, according to the release.